PetVivo Holdings, Inc. (PETV) stock
PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.75+0.00 (0.00%)
Close on Oct 19, 2026Market cap $27.79MP/E –Yield –
PetVivo gross margin
Gross margin is gross profit as a percentage of revenue.
PetVivo's gross margin for the twelve months ending Jun 30, 2026 was 67.0%. For fiscal 2026 it was 66.1%, against 87.8% the year before. The highest annual figure on record is 100.0% in fiscal 2016.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | 66.1% | −21.7 |
| FY2025 | Mar 31, 2025 | 87.8% | −1.6 |
| FY2024 | Mar 31, 2024 | 89.5% | +13.6 |
| FY2023 | Mar 31, 2023 | 75.9% | +149.9 |
| FY2022 | Mar 31, 2022 | -74.0% | −89.0 |
| FY2021 | Mar 31, 2021 | 15.0% | +464.3 |
| FY2020 | Mar 31, 2020 | -449.3% | −549.3 |
| FY2018 | Mar 31, 2018 | 100.0% | +0.0 |
| FY2017 | Mar 31, 2017 | 100.0% | +0.0 |
| FY2016 | Mar 31, 2016 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | 66.2% | +3.4 |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | 79.8% | −1.5 |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | 50.6% | −38.9 |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | 72.6% | −16.9 |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | 62.8% | −26.7 |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | 81.3% | −8.0 |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | 89.5% | −0.0 |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | 89.5% | −0.0 |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | 89.5% | −0.0 |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | 89.3% | −173.0 |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | 89.5% | +33.4 |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | 89.5% | +55.8 |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | 89.5% | +80.6 |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | 262.3% | +337.4 |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | 56.1% | +150.2 |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | 33.6% | −66.4 |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | 8.9% | +30.7 |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -75.1% | +21.0 |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -94.1% | −194.1 |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | 100.0% | +7.3 |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -21.9% | −121.9 |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -96.1% | +248.2 |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | 100.0% | +429.0 |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | 92.7% | −7.3 |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | 100.0% | +0.0 |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -344.3% | −444.3 |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -329.0% | −429.0 |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | 100.0% | +0.0 |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | 100.0% | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | 100.0% | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | 100.0% | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | 100.0% | – |
See a number that looks wrong?